NYSE:ARDT Ardent Health Partners (ARDT) Stock Price, News & Analysis $12.52 +0.74 (+6.28%) As of 04/14/2025 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Ardent Health Partners Stock (NYSE:ARDT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ardent Health Partners alerts:Sign Up Key Stats Today's Range$11.87▼$12.5450-Day Range$11.76▼$15.3152-Week Range$11.60▼$20.72Volume536,221 shsAverage Volume407,002 shsMarket Capitalization$1.79 billionP/E RatioN/ADividend YieldN/APrice Target$20.58Consensus RatingBuy Company OverviewArdent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Read More… Remove Ads Receive ARDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ardent Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDT Stock News HeadlinesArdent Health Partners (NYSE:ARDT) Price Target Lowered to $18.00 at MizuhoApril 12 at 2:51 AM | americanbankingnews.comArdent Health price target lowered to $18 from $19 at MizuhoApril 10, 2025 | markets.businessinsider.comWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.April 15, 2025 | Altimetry (Ad)Ardent Health initiated with a Buy at GuggenheimApril 10, 2025 | markets.businessinsider.comGuggenheim Initiates Coverage of Ardent Health Partners (ARDT) with Buy RecommendationApril 9, 2025 | msn.comLeerink Partnrs Issues Optimistic Outlook for ARDT EarningsApril 5, 2025 | americanbankingnews.comArdent Health Appoints Robert DeMichiei to Board of DirectorsApril 3, 2025 | gurufocus.comArdent Health Appoints Robert DeMichiei to Board of DirectorsApril 3, 2025 | businesswire.comSee More Headlines ARDT Stock Analysis - Frequently Asked Questions How have ARDT shares performed this year? Ardent Health Partners' stock was trading at $17.08 at the beginning of the year. Since then, ARDT shares have decreased by 26.7% and is now trading at $12.52. View the best growth stocks for 2025 here. How were Ardent Health Partners' earnings last quarter? Ardent Health Partners, LLC (NYSE:ARDT) issued its quarterly earnings results on Wednesday, February, 26th. The company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion. Read the conference call transcript. When did Ardent Health Partners IPO? Ardent Health Partners (ARDT) raised $192 million in an initial public offering (IPO) on Thursday, July 18th 2024. The company issued 12,000,000 shares at a price of $16.00 per share. Who are Ardent Health Partners' major shareholders? Top institutional shareholders of Ardent Health Partners include Rhumbline Advisers (0.02%). How do I buy shares of Ardent Health Partners? Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ardent Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health Partners investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML). Company Calendar Last Earnings2/26/2025Today4/14/2025Next Earnings (Estimated)5/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry General medical & surgical hospitals Sub-IndustryHealthcare Current SymbolNYSE:ARDT Previous SymbolNYSE:ARDT CIK1756655 WebN/A Phone(615) 296-3000FaxN/AEmployees24,200Year FoundedN/APrice Target and Rating Average Stock Price Target$20.58 High Stock Price Target$25.00 Low Stock Price Target$16.00 Potential Upside/Downside+64.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.78 Current Ratio1.91 Quick Ratio1.78 Sales & Book Value Annual Sales$5.97 billion Price / Sales0.30 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares142,750,000Free FloatN/AMarket Cap$1.79 billion OptionableOptionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NYSE:ARDT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardent Health Partners, LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardent Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.